Company Description
Precision Therapeutics helps make the fight against cancer personal. The company develops and markets its ChemoFx tests for use with solid tumor...
Key Precision Therapeutics Financials
| Company Type | Private - NASDAQ (GM): PRCN Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $0.8 |
| 2006 Employees | 65 |
More Precision Therapeutics Financials (4 pages)
Latest Precision Therapeutics Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Precision Therapeutics's competition across multiple industries
Top Precision Therapeutics Competitors
Sponsored Links
The Business Directory
Precision Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Sean C. McDonald | Network | E-mail |
| VP Business Development and Finance | Sharon S. Kim | Network | E-mail |
| CTO | Michael J. (Mike) Gabrin | Network | E-mail |
More Precision Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Sponsored Opportunity
